{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:56:12Z","timestamp":1776376572975,"version":"3.51.2"},"reference-count":84,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eprac.2024.07.010","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T08:32:18Z","timestamp":1721291538000},"page":"908-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9726-3402","authenticated-orcid":false,"given":"Roger R.","family":"Perry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Feliberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marybeth S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2024.07.010_bib1","series-title":"Endotext","article-title":"Pathophysiology and treatment of pancreatic neuroendocrine tumors(PNETs): new developments","author":"Vinik","year":"2018"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.010_bib3","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/diagnostics11112030","article-title":"Incidence, clinical presentation and trends in indication for diagnostic work-up of small intestinal and pancreatic neuroendocrine tumors","volume":"11","author":"Stensbol","year":"2021","journal-title":"Diagnostics"},{"issue":"24","key":"10.1016\/j.eprac.2024.07.010_bib4","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, Part 1: National cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.eprac.2024.07.010_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12885-019-5543-2","article-title":"Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.010_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallett","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.eprac.2024.07.010_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13343","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours","author":"Kos-Kudla","year":"2023","journal-title":"J\u00a0Neuroendocrinology"},{"key":"10.1016\/j.eprac.2024.07.010_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13318","article-title":"European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes","volume":"35","author":"Hofland","year":"2023","journal-title":"J\u00a0Neuroendocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2024.07.010_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","article-title":"The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors","volume":"49","author":"Halfdanarson","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.eprac.2024.07.010_bib11","series-title":"Neuroendocrine and Adrenal Tumors, Neuroendocrine Tumors of the Pancreas (Well-Differentiated Grade 1\/2)","year":"2024"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.010_bib12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jamcollsurg.2016.11.014","article-title":"National rise in pancreatic carcinoid tumors: Comparison to functional and non-functional pancreatic neuroendocrine tumors","volume":"224","author":"Kasumova","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"issue":"9","key":"10.1016\/j.eprac.2024.07.010_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/14737140.2018.1496822","article-title":"Imaging of Pancreatic Neuroendocrine Tumors: recent advances, currents status and controversies","volume":"18","author":"Lee","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11547-017-0734-x","article-title":"Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics","volume":"112","author":"Zhu","year":"2017","journal-title":"Radiol Med"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2214\/AJR.19.21921","article-title":"Grade 3 pancreatic neuroendocrine tumors on MDCT: establishing a diagnostic model and comparing survival against pancreatic ductal adenocarcinoma","volume":"215","author":"Chen","year":"2020","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.eprac.2024.07.010_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.654975","article-title":"The impact of 68Gallium DOT PET\/CT in managing patients WITH sporadic and familial pancreatic neuroendocrine tumours","volume":"12","author":"Cuthbertson","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11864-022-00967-z","article-title":"New PET radiotracers for the imaging of neuroendocrine neoplasms","volume":"23","author":"Fortunati","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.eprac.2024.07.010_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.25259\/Cytojournal_4_2020","article-title":"Grading of pancreatic neuroendocrine tumors on endoscopic ultrasound-guided fine-needle aspiration using Ki-67 index and 2017 World Health Organization criteria: an analysis of 32 cases","volume":"17","author":"Kalantri","year":"2020","journal-title":"CytoJournal"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000477213","article-title":"Analysis of pancreatic neuroendocrine tumour grading by endoscopic -guided fine needle aspiration: analysis of a large cohort and perspectives for improvement","volume":"106","author":"Boutsen","year":"2018","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.010_bib21","doi-asserted-by":"crossref","first-page":"e1284","DOI":"10.1097\/SLA.0000000000005390","article-title":"Grading pancreatic neuroendocrine tumors via endoscopic ultrasound-guided fine needle aspiration: a multi-institutional study","volume":"2767","author":"Javed","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152149","article-title":"Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3(PHH3), and BCL-2","volume":"65","author":"Zhao","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.eprac.2024.07.010_bib23","series-title":"WHO Classification of Tumors: Digestive System","first-page":"295","article-title":"Tumors of the pancreas","author":"Gill","year":"2019"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000457956","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification","volume":"105","author":"Perren","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.21037\/jgo.2020.03.07","article-title":"Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification, and prognostication","volume":"11","author":"Taskin","year":"2020","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.eprac.2024.07.010_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.eprac.2024.07.010_bib27","series-title":"AJCC cancer staging Manuel","author":"Amin","year":"2017"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.surg.2020.11.015","article-title":"Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study","volume":"169","author":"Fusai","year":"2021","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.010_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.24318","article-title":"Evaluation of outcomes following surgery for locally advanced pancreatic neuroendocrine tumors","volume":"3","author":"Titan","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eprac.2024.07.010_bib30","series-title":"Textbook of Endocrine Surgery","article-title":"Pancreatic surgery for endocrine tumors(chapter 100)","author":"Perry","year":"2016"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjsurg.2020.12.013","article-title":"Small pancreatic neuroendocrine tumors: resect or enucleate","volume":"222","author":"Beane","year":"2021","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11605-017-3365-6","article-title":"Pancreatic neuroendocrine tumors (panNETs): analysis of overall survival of nonsurgical management versus surgical resection","volume":"21","author":"Finklestein","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/SLA.0000000000005559","article-title":"Long-term outcomes of parenchyma-sparing and oncologic resections in patients with nonfunctional pancreatic neuroendocrine tumors < 3cm in a large multicenter cohort","volume":"276","author":"Bolm","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11605-020-04521-w","article-title":"Role of lymph node resection and histopathological evaluation in accurate staging of nonfunctional pancreatic neuroendocrine tumors: how many are enough?","volume":"25","author":"Ding","year":"2021","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11605-014-2624-z","article-title":"Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection","volume":"19","author":"Curran","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/cancers16020440","article-title":"When should lymphadenectomy Be performed in non-metastatic pancreatic neuroendocrine tumors? A population-based analysis of the German clinical cancer registry group","volume":"16","author":"Abdalla","year":"2024","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.eprac.2024.07.010_bib37","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11605-013-2360-9","article-title":"Nonfunctional pancreatic neuroendocrine tumors <2cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival","volume":"17","author":"Toste","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.eprac.2024.07.010_bib38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/MPA.0000000000000861","article-title":"Regional behavior of nonfunctional pancreatic neuroendocrine tumors: impact of lymph node positivity on survival","volume":"46","author":"Jutric","year":"2017","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.surg.2019.03.008","article-title":"The conundrum of <2cm pancreatic neuroendocrine tumors: a preoperative risk score to predict lymph node metastases and guide surgical management","volume":"166","author":"Lopez-Aguiar","year":"2019","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/cancers12051235","article-title":"A\u00a0preoperative clinical risk score including C-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: an international multicenter cohort study","volume":"12","author":"Primavesi","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib41","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/XCS.0000000000000144","article-title":"Validated risk-score model predicting lymph node metastases in patients with non-functional gastroenteropancreatic neuroendocrine tumors","volume":"234","author":"Shannon","year":"2022","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/SLA.0000000000000348","article-title":"Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs)","volume":"259","author":"Hashim","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib43","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1245\/s10434-023-14758-9","article-title":"Accuracy and prognostic impact of nodal status on preoperative imaging for management of pancreatic neuroendocrine tumors: a multi-institutional study","volume":"31","author":"Zhang","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"10.1016\/j.eprac.2024.07.010_bib44","first-page":"6778","article-title":"Optimal lymphadenectomy in patients with well-differentiated nonfunctioning pancreatic neuroendocrine neoplasms","volume":"12","author":"Shintakuya","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.eprac.2024.07.010_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.890564","article-title":"Impact of surgery on non-functional pancreatic neuroendocrine tumors < 2 cm: analyses with propensity score-based inverse probability of treatment weighting","volume":"9","author":"Ye","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.871830","article-title":"Patterns of lymph node metastasis and optimal surgical strategy in small (<20mm) gastroenteropancreatic neuroendocrine tumors","volume":"13","author":"Cai","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2024.07.010_bib47","first-page":"2993","article-title":"Surgical management of neuroendocrine tumours of the pancreas","volume":"9","author":"Souche","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jso.25481","article-title":"Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: an analysis form the U.S. neuroendocrine tumor study group","volume":"120","author":"Zhang","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/XCS.0000000000000257","article-title":"Minimally invasive vs open pancreatectomy for pancreatic neuroendocrine tumors: multi-institutional 10-year experience of 1,023 patients","volume":"235","author":"Zheng","year":"2022","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/EUS-D-21-00044","article-title":"EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: a systematic review and meta-analysis","volume":"11","author":"Garg","year":"2022","journal-title":"Endosc Ultrasound"},{"issue":"7","key":"10.1016\/j.eprac.2024.07.010_bib51","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/jc.2019-00282","article-title":"Endoscopic ultrasound-guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors","volume":"104","author":"Oleinikov","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.07.010_bib52","first-page":"3325","article-title":"Endoscopic ultrasound-guided local ablative therapies for the treatment of pancreatic neuroendocrine tumors and cystic lesions: a review of the current literature","volume":"12","author":"Prete","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/SLA.0b013e318265f08d","article-title":"Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome","volume":"256","author":"Norton","year":"2012","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.eprac.2024.07.010_bib54","first-page":"1799","article-title":"Surgical Management of insulinoma over three decades","volume":"23","author":"de Carbonnieres","year":"2021","journal-title":"HPB(Oxford)"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.010_bib55","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1245\/s10434-015-4986-1","article-title":"Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study","volume":"23","author":"Sadot","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.eprac.2024.07.010_bib56","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1245\/s10434-017-5946-8","article-title":"Sporadic small (< 20mm) nonfunctioning pancreatic neuroendocrine neoplasm: is the risk of malignancy negligible when adopting a more conservative strategy? A systematic review and meta-analysis","volume":"24","author":"Ricci","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.eprac.2024.07.010_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hpb.2017.08.034","article-title":"Prognosis of sporadic resected small (< 2cm) nonfunctional pancreatic neuroendocrine tumors- a multi-institutional study","volume":"20","author":"Sallinen","year":"2018","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bjs.10312","article-title":"Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms","volume":"104","author":"Partelli","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib59","article-title":"Reappraisal of a 2-cm cutoff size for the management of nonfunctional pancreatic neuroendocrine tumors: a population-based study","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2024.07.010_bib60","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/bjs\/znab088","article-title":"Watchful waiting for small non-functional pancreatic neuroendocrine tumors: nationwide prospective cohort study(PANDORA)","volume":"108","author":"Heidsma","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib61","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/bjs\/znac267","article-title":"Management of asymptomatic sporadic\u00a0non-functioning pancreatic neuroendocrine neoplasm no larger than 2cm: interim analysis of perspective ASPEN trial","volume":"109","author":"Partelli","year":"2022","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00268-018-4751-2","article-title":"Implementation of current ENETS guidelines for surgery of small neuroendocrine neoplasms in the German surgical community: an analysis of the prospective DGAV StuDoQ\/pancreas registry","volume":"43","author":"Mintziras","year":"2019","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.eprac.2024.07.010_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.surg.2019.04.003","article-title":"Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: limitations to apply guidelines into real life","volume":"166","author":"Partelli","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.surg.2019.04.061","article-title":"Operative resection in early stage pancreatic neuroendocrine tumors in the United States: are we over- or undertreating patients?","volume":"167","author":"Chivukula","year":"2020","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.010_bib65","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/ERC-19-0372","article-title":"Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature","volume":"27","author":"Sadowski","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.eprac.2024.07.010_bib66","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1055-3207(18)30250-3","article-title":"Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"7","author":"Thompson","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"issue":"32","key":"10.1016\/j.eprac.2024.07.010_bib67","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1200\/JCO.23.01529","article-title":"Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guidelines","volume":"41","author":"Rivero","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eprac.2024.07.010_bib68","first-page":"1998","article-title":"Systemic treatment selection for patients with advanced pancreatic neuroendocrine tumors(panNETs)","volume":"12","author":"Magdanova-Chipeva","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.eprac.2024.07.010_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.amjsurg.2023.09.035","article-title":"Decreasing utilization of surgical interventions amongst patients with pancreatic neuroendocrine tumor with liver metastases","volume":"227","author":"Amini","year":"2024","journal-title":"Am J Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MD.0000000000026347","article-title":"Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors. A SEER based study","volume":"100","author":"Ge","year":"2021","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.010_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00423-015-1323-x","article-title":"Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based propensity score-matched survival analysis","volume":"400","author":"Huttner","year":"2015","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.eprac.2024.07.010_bib72","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jss.2019.04.002","article-title":"Palliative resection of primary tumor in metastatic nonfunctioning pancreatic neuroendocrine tumors","volume":"243","author":"Ye","year":"2019","journal-title":"J\u00a0Surg Res"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib73","doi-asserted-by":"crossref","first-page":"590","DOI":"10.21037\/jgo.2019.11.02","article-title":"Surgical management of pancreatic neuroendocrine liver metastases","volume":"11","author":"Cloyd","year":"2020","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.eprac.2024.07.010_bib74","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/cancers14061478","article-title":"Orchestrating treatment Modalities in metastatic pancreatic neuroendocrine tumors-need for a conductor","volume":"14","author":"Siebenhuner","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.eprac.2024.07.010_bib75","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1093\/oncolo\/oyab041","article-title":"Position statement on the diagnosis, treatment, and response evaluation to systemic therapies of advanced neuroendocrine tumors, with a special focus on radioligand therapy","volume":"27","author":"Capdevila","year":"2022","journal-title":"Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.010_bib76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11154-017-9431-2","article-title":"Liver transarterial embolizations in metastatic neuroendocrine tumors","volume":"18","author":"de Mestier","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.010_bib77","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.surg.2017.11.007","article-title":"Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms","volume":"163","author":"Partelli","year":"2018","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.010_bib78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ags3.12458","article-title":"Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms","volume":"5","author":"Murase","year":"2021","journal-title":"Ann Gastroenterol Surg"},{"issue":"11","key":"10.1016\/j.eprac.2024.07.010_bib79","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jamaoncol.2018.2428","article-title":"Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors","volume":"4","author":"Singh","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.010_bib80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000518757","article-title":"International validation of a nomogram to predict recurrence after resection of grade 1 and 2 nonfunctioning pancreatic neuroendocrine tumors","volume":"112","author":"Heidsma","year":"2022","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.010_bib81","article-title":"Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: a SEER based study","volume":"13","author":"Lin","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.eprac.2024.07.010_bib82","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/bjs\/znaa141","article-title":"Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis","volume":"108","author":"Ricci","year":"2021","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.010_bib83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000495774","article-title":"Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, where?","volume":"108","author":"Marchegiani","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.eprac.2024.07.010_bib84","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1245\/s10434-023-13117-y","article-title":"Prognostic significance and predictors of nodal recurrence after surgery for non-functioning pancreatic neuroendocrine tumors","volume":"30","author":"Partelli","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T09:57:06Z","timestamp":1727776626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24006086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":84,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1530891X24006086"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.07.010","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}